Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: Implications for addiction

Drug and Alcohol Dependence

Volumn 56, Issue 2, 1999, Pages 99-107

  Rose, Jed E ^a,b   Behm, Frederique M ^b   Westman, Eric C ^a,b   Coleman, R Edward ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nicotine kinetics; Puff topography; Smoking; Tobacco

Indexed keywords

NICOTINE;

ARTERIAL BLOOD; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INHALATION; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BEHAVIOR, ADDICTIVE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LUNG; MALE; MIDDLE AGED; NICOTINE; SMOKING;

EID: 0032769141     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00025-3     Document Type: Article

References (36)

1. Benowitz N.L., Porchet H., Jacob P.I. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology. 1990;112-157 Oxford University Press, Oxford.
2. Bowman W.C., Rand M.J. Textbook of Pharmacology. 1980;Blackwell, London.
3. Smoking cessation during previous year among adults - United States, 1990 and 1991. Morb. Mortal. Wkly. Rep. 42:1993;504-507.
4. Evans S.M., Cone E.J., Henningfield J.E. Arterial and venous cocaine plasma concentrations in humans: relationship of route of administration, cardiovascular effects and subjective effects. J. Pharmacol. Exp. Ther. 279:1996;1345-1356.
5. Federal Trade Commission, 1997. 'Tar', nicotine and carbon monoxide of the smoke of 1206 varieties of domestic cigarettes. Federal Trade Commission, Washington, DC.
6. Fiore M.C., Smith S.S., Jorenby D.E., Baker T.B. The effectiveness of the nicotine patch in smoking cessation. J. Am. Med. Assoc. 271:1994;1940-1947.
7. Gilbert D.G., Jensen R.A., Meliska C.J. A system for administering quantified doses of tobacco smoke to human subjects: plasma nicotine and filter pad validation. Pharmacol. Biochem. Behav. 31:1989;905-908.
8. Ginzel K.H., Eldred E. Reflex depression of somatic motor activity from heart, lungs and carotid sinus. Paintal A.S., Gill-Kumar P. Krogh Centenary Symposium on Respiratory Adaptation, Capillary Exchange and Reflex Mechanisms. 1977;358-395 Vallabhbai Patel Chest Institute, University of Delhi, Delhi.
9. Gorsline J. Nicotine pharmacokinetics of four nicotine transdermal systems. Health Values. 17:1993;20-24.
10. Gourlay S.G., Benowitz N.L. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin. Pharmacol. Ther. 62:1997;453-463.
11. 3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. J. Pharmacol. Exp. Ther. 282:1997;32-43.
12. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.L. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 86:1991;1119-1127.
13. Henningfield J., Stapleton J.M., Benowitz N.L., Grayson R.F., London E.D. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:1993;23-29.
14. Herning R.I., Jones R.T., Bachman J., Mines A.H. Puff volume increases when low-nicotine cigarettes are smoked. Br. Med. J. 283:1981;187-189.
15. Jacob P., Wilson M., Benowitz N. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J. Chromatogr. 222:1981;61-70.
16. Legget R.W., Williams L.R. A proposed blood circulation model for reference man. Health Phys. 69:1995;187-201.
17. Levin E.D., Rose J.E., Behm F. Controlling puff volume without disrupting smoking topography. Behav. Res. Methods Instrum. Comput. 21:1989;383-386.
18. Lunell E., Bergstrom M., Antoni G., Långström B., Nordberg A. Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clin. Pharmacol. Ther. 59:1996;593-594.
19. Maus A.D.J., Pereira E.F.R., Karachunski P.I. et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol. Pharmacol. 54:1998;779-788.
20. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
21. Moreyra A.E., Lacy C.R., Wilson A.C., Kumar A., Kostis J.B. Arterial blood nicotine concentration and coronary vasoconstrictive effect of low-nicotine cigarette smoking. Am. Heart J. 124:1992;392-397.
22. Olale F., Gerzanich V., Kuryatov A., Wang F., Lindstrom J. Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283:1997;675-683.
23. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., van Huijsduijnen R.H., Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science. 275:1997;83-86.
24. Plowchalk D.R., Andersen M.E., DeBethizy J.D. A physiologically based pharmacokinetic model for nicotine disposition in the Spraugue-Dawley rat. Toxicol. Appl. Pharmacol. 116:1992;177-188.
25. Rahimian J., Glass E.C., Touya J.J., Akber F., Graham L.S., Bennett L.R. Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique. J. Nucl. Med. 25:1984;31-37.
26. Rose J.E., Westman E.C., Behm F.M., Johnson M.P., Goldberg J.S. Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol. Biochem. Behav. 62:1999;165-172.
27. Rose J.E., Wu T.-C., Djahed B., Tashkin D.P. Noninvasive measurement of smokers' tar and nicotine intake. Behav. Res. Methods Instrum. Comp. 19:1987;295-299.
28. Rowell P.P. Nanomolar concentrations of nicotine increase the release of [3H]dopamine from rat striatal synaptosomes. Neurosci. Lett. 189:1995;171-175.
29. Russell M.A.H., Feyerabend C. Cigarette smoking: a dependence on high-nicotine boli. Drug Metabol. Rev. 8:1978;29-57.
30. Suhara T., Sudo Y., Yoshida K. et al. Lung as reservoir for antidepressants in pharmacokinetic drug interactions. Lancet. 351:1998;332-335.
31. U.S.D.H.H.S., 1988. The Health Consequences of Smoking: Nicotine Addiction. Office on Smoking and Health, Centers for Disease Control, Rockville, MD.
32. U.S.D.H.H.S., 1990. The Health Benefits of Smoking Cessation. A Report of the Surgeon General. Public Health Service, Rockville, MD.
33. Vestal R.E., Kornhauser D.M., Shand D.G. Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines. J. Pharmacol. Exp. Ther. 214:1980;106-111.
34. Wilson A.G.E., Sar M., Stumpf W.E. Autoradiographic localization of imipramine localization in the isolated perfused rabbit lung. Drug Metab. Dispos. 10:1982;281-283.
35. Wonnacott S. Characterization of nicotine receptor sites in the brain. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology: Molecular, Cellular, and Behavioural Aspects. 1990;226-277 Oxford University Press, New York.
36. Young J.C., Robinson J.C., Rickert W.S. A study of chemical deliveries as a function of cigarette butt length. Beitr. Tabakforsh. Int. 11(2):1981;87-95.